Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. products
  3. usa nevada
  4. testing services targeting to preclinical studies
Show results for

Refine by
Locations
Back to All Locations

  • USA
  • Nevada
Brands

  • clearside

Clearside Testing Services Targeting To Preclinical Studies Equipment & Supplies In In Usa Nevada

3 equipment items found
Available In NevadaNear Nevada

Clearside - Gene Therapy Technology

Clearside - Gene Therapy Technology

Manufactured by:Clearside Biomedical   based inAlpharetta, GEORGIA (US) (USA)
We believe our platform offers the potential for safer, targeted ocular gene therapy without some of the risks of surgery and subretinal administration. Suprachoroidal administration of gene therapy could ultimately enhance access to care because it does not require specialized gene therapy surgery treatment centers. The procedure for suprachoroidal injection is conducted in an office setting and ...
CONTACT SUPPLIER

Clearside - Model Integrin Inhibitor - Targeted Delivery Beyond Anti-VEGF Therapy

Clearside - Model Integrin Inhibitor - Targeted Delivery Beyond Anti-VEGF Therapy

Manufactured by:Clearside Biomedical   based inAlpharetta, GEORGIA (US) (USA)
As part of our small molecule program, we are evaluating the suprachoroidal administration of an integrin inhibitor suspension. Integrins play a role in pathologic processes, such as inflammation, angiogenesis and fibrosis. Suprachoroidal delivery of an integrin inhibitor suspension could provide targeting, compartmentalization and durability advantages over topical or intravitreal delivery, ...
CONTACT SUPPLIER

Clearside - Model CLS-AX - Axitinib Injectable Suspension

Clearside - Model CLS-AX - Axitinib Injectable Suspension

Manufactured by:Clearside Biomedical   based inAlpharetta, GEORGIA (US) (USA)
CLS-AX (axitinib injectable suspension) is a proprietary suspension of axitinib for suprachoroidal use. Axitinib is a tyrosine kinase inhibitor (TKI) currently approved to treat renal cell cancer that achieves pan-VEGF blockade, directly inhibiting VEGF receptors-1, -2, and -3 with high potency and specificity. We believe this broad VEGF blockade may have efficacy advantages over existing retinal ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT